chr2-74490044-G-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_022492.6(TTC31):​c.149G>A​(p.Arg50Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,561,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

TTC31
NM_022492.6 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.44

Publications

0 publications found
Variant links:
Genes affected
TTC31 (HGNC:25759): (tetratricopeptide repeat domain 31)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.045057535).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC31NM_022492.6 linkc.149G>A p.Arg50Gln missense_variant Exon 3 of 13 ENST00000233623.11 NP_071937.4 Q49AM3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC31ENST00000233623.11 linkc.149G>A p.Arg50Gln missense_variant Exon 3 of 13 1 NM_022492.6 ENSP00000233623.6 Q49AM3-1

Frequencies

GnomAD3 genomes
AF:
0.0000396
AC:
6
AN:
151696
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000884
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000568
AC:
10
AN:
176048
AF XY:
0.0000320
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000136
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000127
AC:
179
AN:
1410216
Hom.:
0
Cov.:
35
AF XY:
0.000105
AC XY:
73
AN XY:
696798
show subpopulations
African (AFR)
AF:
0.0000617
AC:
2
AN:
32390
American (AMR)
AF:
0.00
AC:
0
AN:
36838
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37330
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80526
European-Finnish (FIN)
AF:
0.0000199
AC:
1
AN:
50286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5558
European-Non Finnish (NFE)
AF:
0.000158
AC:
171
AN:
1083832
Other (OTH)
AF:
0.0000857
AC:
5
AN:
58330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000396
AC:
6
AN:
151696
Hom.:
0
Cov.:
32
AF XY:
0.0000405
AC XY:
3
AN XY:
74048
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41304
American (AMR)
AF:
0.00
AC:
0
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000884
AC:
6
AN:
67902
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000148
Hom.:
0
Bravo
AF:
0.0000567
ExAC
AF:
0.000143
AC:
17

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 13, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.149G>A (p.R50Q) alteration is located in exon 3 (coding exon 3) of the TTC31 gene. This alteration results from a G to A substitution at nucleotide position 149, causing the arginine (R) at amino acid position 50 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
11
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0066
.;.;T
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.72
T;T;T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.045
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.4
L;.;L
PhyloP100
-1.4
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.3
.;N;N
REVEL
Benign
0.020
Sift
Benign
0.15
.;T;T
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.052
.;.;B
Vest4
0.18
MVP
0.26
MPC
0.097
ClinPred
0.053
T
GERP RS
-0.14
Varity_R
0.034
gMVP
0.22
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768286943; hg19: chr2-74717171; API